Stem Cell/Cord Blood Banking Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | AMAG Pharmaceuticals Inc., Cryo-Cell International Inc., Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Stem Cell/Cord Blood Banking Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The stem cell/cord blood banking market size has grown strongly in recent years. It will grow from $11.14 billion in 2023 to $12.19 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to medical advancements, increased awareness, successful clinical applications, regulatory support, research funding.

The stem cell/cord blood banking market size is expected to see rapid growth in the next few years. It will grow to $18.83 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to personalized medicine, emerging therapies, international expansion, investment in biotechnology, legal and ethical framework. Major trends in the forecast period include non-invasive collection methods, multiple banking services, transparency and regulation, collaborative efforts, storage innovations.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2514&type=smp

Market Segmentation:
The main cell types of stem cell/cord blood banking are adult stem cells, umbilical cord blood stem cells, and embryonic stem cells. Adult stem cells are a rare population of cells found in the body for the majority of postnatal life that give rise to a limited number of mature cell types that form the tissue in which they dwell. The different types of services include collection, processing, analysis, storage and involves various types of banks such as private banks, and public banks. The different applications include leukemia, anemia, thalassemia, autism, cerebral palsy, diabetes, and others.

Major Driver - Cancer Patients Drive Growth In Stem Cell And Cord Blood Banking Market
Increasing number of cancer patients is a major driver for the stem cell /cord blood banking market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant in which the stem cells come from the same person who gets the transplant or by allogeneic transplant in which means the stem cells come from a matched related or unrelated donor. By using stem cells in the treatment of cancer, the blood forming stem cells which are damaged during chemotherapy can be restored. According to a report by WebMD,an American publisher of health related news, in 2021, 10 million people died of cancer worldwide. which can be treated by transplanting the stem cells.

Competitive Landscape:
Major companies operating in the stem cell/cord blood banking market include AMAG Pharmaceuticals Inc., Cryo-Cell International Inc., Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Ltd., CordVida, Cryo Stemcell, PerkinElmer Inc., ReeLabs Pvt Ltd., Smart Cells International Ltd., Stemade Biotech Pvt Ltd., ViaCord Inc., Americord Registry LLC, LifeCell International, Cryoviva Biotech Pvt Ltd., Cytori Therapeutics Inc., Thermo Fisher Scientific Inc., Cord Blood America Inc., StemCyte Inc., Brainstorm Cell Therapeutics Inc., Cord Blood Registry Systems Inc., Healthbanks Biotech Usa Inc., Cryo-save Private Ltd., New York Cord Blood Center, CryoHoldco, Vita 34 International AG, Reliance Life Sciences Pvt Ltd., Maze Cord Blood Laboratories, Cells4Life Group LLP

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Top Trend - Cord Blood And Tissue Storage Paired With Genetic Testing Services In Stem Cell Banking
Pairing of cord blood and tissue storage with genetic testing services is an emerging trend in the stem cell/cord blood banking market. Such pairing is possible and efficient because of its complimentary services to the existing clients, thereby helping in expanding their product portfolio. For example, genetic testing company Natera launched the Evercord cord blood and tissue storage service that enables expectant parents to collect, store and potentially retrieve their newborn's cord blood and tissue for therapeutic use in transplantation and regenerative medicine applications.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Stem Cell/Cord Blood Banking Market Characteristics
3. Stem Cell/Cord Blood Banking Market Trends And Strategies
4. Stem Cell/Cord Blood Banking Market - Macro Economic Scenario
5. Stem Cell/Cord Blood Banking Market Size And Growth
…..
27. Stem Cell/Cord Blood Banking Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.